Profile

Spiderwort is a biomaterials company developing cellulose-based scaffolds for use in regenerative medicine. Its lead CelluBridge program addressing spinal cord injury has received a Breakthrough Device Designation from the FDA. CelluJuve is a secondary application for use as a long-lasting dermal filler.

Spiderwort Inc. Logo

Website

www.spiderwortbio.com

Contact


Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

26 in total